Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Qualification of Titrators in Liquid Preparation

Posted on By

SOP for Qualification of Titrators in Liquid Preparation

Standard Operating Procedure for Qualification of Titrators in Liquid Preparation

1) Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the process for qualifying titrators used in liquid preparation within pharmaceutical manufacturing. This SOP ensures that the titrators are correctly installed, calibrated, and operate in compliance with the required specifications. The qualification process verifies that the titration method is accurate, reproducible, and capable of providing reliable results, ensuring the quality and consistency of liquid formulations. The titrator must perform according to established parameters to meet regulatory requirements and product quality standards.

2) Scope

This SOP applies to the qualification of titrators used in pharmaceutical manufacturing for determining the concentration of active ingredients, pH, and other relevant parameters in liquid formulations. The qualification process includes Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). This SOP is applicable to both new titrators and those that have undergone significant maintenance, repairs, or relocations. The qualification ensures that the titrator performs effectively under typical operating conditions and provides consistent, accurate, and reproducible results.

3) Responsibilities

Operators: Responsible for assisting in the IQ, OQ, and PQ processes, ensuring that the titrator is operated according to the qualification

protocols, and that critical parameters are monitored and recorded during testing.
Quality Assurance (QA): Ensures that the IQ, OQ, and PQ of the titrator are carried out in compliance with this SOP and meet all regulatory requirements. QA is responsible for reviewing and approving all qualification reports and documentation.
Production Supervisors: Oversee the qualification processes to ensure that operators follow the protocol and that the titrator operates within the specified parameters.
Validation Team: Responsible for developing the qualification protocols, executing the IQ, OQ, and PQ runs, and analyzing the results to ensure the titrator meets all performance criteria.
Maintenance Personnel: Ensures that the titrator is properly installed, calibrated, and maintained, and that all mechanical and electrical systems are functioning correctly during the qualification process.

See also  SOP for Validation of Blending Process for Powders

4) Procedure

The following steps should be followed for the IQ, OQ, and PQ of titrators in liquid preparation:

1. Installation Qualification (IQ):
1.1 Review the titrator’s specifications and manufacturer manuals to ensure that the equipment meets the necessary installation requirements.
1.2 Verify that all required utilities (e.g., electrical power, water supply, compressed air, solvents) are available and meet the specifications required for operation.
1.3 Ensure that the installation site meets the required environmental conditions such as temperature, humidity, and space.
1.4 Confirm that all components are correctly installed, including the titration apparatus, sample holders, electrodes, and reagent delivery systems.
1.5 Ensure that all electrical components, such as control panels, sensors, and displays, are correctly connected and functioning.
1.6 Perform a visual inspection to confirm that the equipment is installed according to the manufacturer’s instructions and that all components are intact.
1.7 Complete the IQ documentation, including checklists, equipment manuals, and relevant installation records, ensuring that all information is recorded and signed off by responsible personnel.

2. Operational Qualification (OQ):
2.1 Verify that all operational controls, such as titration speed, reagent flow, and volume measurement, are correctly set and calibrated.
2.2 Conduct a dry run of the titrator to verify that it operates without issues. Monitor key parameters such as reagent delivery, mixing time, and end-point detection.
2.3 Test all control systems, ensuring that the start/stop, titration, and endpoint detection functions work correctly.
2.4 Inspect the titration process to ensure that it provides accurate and consistent results for known standards.
2.5 Verify that the titrator can handle the required sample sizes and types accurately without cross-contamination or loss of reagents.
2.6 Document the results of the OQ, noting any deviations or issues encountered and corrective actions taken.

See also  SOP for Qualification of Syrup Manufacturing Tanks

3. Performance Qualification (PQ):
3.1 Conduct titration tests using standard reference solutions or known concentrations of active ingredients to verify the accuracy and precision of the titrator.
3.2 Verify that the titration results match the expected values within the acceptable tolerance limits.
3.3 Test the titrator with different sample sizes, sample compositions, and reagent types to ensure that it can handle a variety of real-world applications.
3.4 Monitor the titration process for repeatability by performing multiple runs on the same sample and comparing results.
3.5 Verify that the titrator operates within the required throughput and provides consistent and reliable results under typical operating conditions.
3.6 Document the results of the PQ, including accuracy, precision, repeatability, and any process deviations. Ensure that all records are signed and reviewed by responsible personnel.

4. Documentation and Reporting:
4.1 Record all data during the IQ, OQ, and PQ processes, including batch records, equipment logs, process parameters, and inspection results for titration accuracy, sample handling, and reagent delivery.
4.2 Ensure that all forms, reports, and certificates are completed and signed by responsible personnel.
4.3 Perform statistical analysis on the collected data to assess the consistency and reliability of the titration process. This analysis should confirm that the titrator operates consistently within predefined parameters and meets the acceptance criteria for accuracy and precision.
4.4 Prepare a final qualification report, summarizing the results of the IQ, OQ, and PQ, including any deviations, corrective actions, and conclusions regarding the titrator’s performance.

See also  SOP for Installation Qualification (IQ) of Tablet Compression Machines

5. Requalification:
5.1 Requalify the titrator if significant changes are made to the equipment, such as replacing major components, relocating the titrator, or modifying the titration system.
5.2 Periodically perform requalification to ensure that the equipment continues to perform as expected and remains in compliance with regulatory requirements.

5) Abbreviations

  • IQ: Installation Qualification
  • OQ: Operational Qualification
  • PQ: Performance Qualification
  • QA: Quality Assurance
  • SOP: Standard Operating Procedure

6) Documents

  • IQ/OQ/PQ Protocol
  • Equipment Manufacturer Specifications
  • Installation and Setup Reports
  • Calibration Records
  • Titration Process Records
  • Reference Solution Logs
  • Deviation and Corrective Action Reports

7) Reference

  • FDA Guidance for Industry: Equipment Qualification
  • International Council for Harmonisation (ICH) Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • ISO 9001: Quality Management Systems – Requirements
  • USP Chapter 1151: Pharmaceutical Dosage Forms

8) SOP Version

Version 1.0 – Effective Date: DD/MM/YYYY

Annexure

Template 1: IQ/OQ/PQ Test Record

Date Time Operator Initials Test Type (IQ/OQ/PQ) Test Results Comments
DD/MM/YYYY HH:MM Operator Name IQ/OQ/PQ Pass/Fail Comments
           

Template 2: Titration Results Log

Batch No. Test Date Concentration (mg/mL) Deviations (%) Pass/Fail Operator Initials
Batch Number DD/MM/YYYY Concentration Value Deviation Pass/Fail Operator Name
           

Template 3: Calibration and Maintenance Log

Equipment Name Calibration Date Maintenance Performed Next Calibration Date Operator Initials
Titrator Model DD/MM/YYYY Maintenance Tasks DD/MM/YYYY Operator Name
         
Validations and Qualifications Tags:Cleaning Validation in Pharmaceutical Industry, Computer System Validation in Pharma, Computer System Validation in Pharmaceuticals, Define Validation in Pharma, Equipment Qualification in Pharma, Method Validation in Pharma, Performance Qualification in Pharma, Pharma Validation, Pharmaceutical Cleaning Validation, Pharmaceutical Method Validation, Pharmaceutical Process Validation, Pharmaceutical Process Validation SOP, Pharmaceutical Validation Definition, Pharmaceutical Validation Services, Process Validation Definition in Pharma, Process Validation in Pharma, Process Validation in Pharma Industry, Process Validation in Pharmaceutical Industry, Prospective Validation in Pharma, Qualification in Pharma, Software Validation in Pharmaceutical Industry, SOP for Analytical Method Validations, SOP for Cleaning Validations, SOP for Equipment Validations, SOP for Process Validation, SOP for Validations, Types of Validation in Pharma, Types of Validation in Pharmaceutical Industry, Validation in Pharmaceutical Industry, Validation Life Cycle in Pharma

Post navigation

Previous Post: SOP for Qualification of Batch Pasteurizers
Next Post: SOP for Biophysical Methods in Drug Discovery

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version